- Home
- Publications
- Publication Search
- Publication Details
Title
A multi-targeted approach to treating bone metastases
Authors
Keywords
Prostate cancer, Bone metastasis, Microenvironment, Targeted therapy, Ecotherapy
Journal
CANCER AND METASTASIS REVIEWS
Volume 33, Issue 2-3, Pages 545-553
Publisher
Springer Nature
Online
2014-01-03
DOI
10.1007/s10555-013-9476-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
- (2013) Shahneen K. Sandhu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Clinical Development of Immunostimulatory Monoclonal Antibodies and Opportunities for Combination
- (2013) I. Melero et al. CLINICAL CANCER RESEARCH
- Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease
- (2013) Harrison et al. Cancer Management and Research
- Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial†
- (2012) M. Reck et al. ANNALS OF ONCOLOGY
- Disrupting the Networks of Cancer
- (2012) D. F. Camacho et al. CLINICAL CANCER RESEARCH
- Bevacizumab-based therapy in relapsed glioblastoma: rationale and clinical experience to date
- (2012) Olivier L Chinot Expert Review of Anticancer Therapy
- Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
- (2012) Kenneth J. Pienta et al. INVESTIGATIONAL NEW DRUGS
- Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial
- (2012) David C. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
- (2012) Kim Margolin et al. LANCET ONCOLOGY
- The role of antiresorptive therapies in improving patient care in early and metastatic breast cancer
- (2011) Dulcinea Candelaria-Quintana et al. BREAST CANCER RESEARCH AND TREATMENT
- Tumor Cells and Tumor-Associated Macrophages: Secreted Proteins as Potential Targets for Therapy
- (2011) Marc Baay et al. Clinical & Developmental Immunology
- PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
- (2011) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- Denosumab for bone diseases: translating bone biology into targeted therapy
- (2011) Elena Tsourdi et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow
- (2011) Yusuke Shiozawa et al. JOURNAL OF CLINICAL INVESTIGATION
- Novel Therapies for Metastatic Castrate-Resistant Prostate Cancer
- (2011) F. Dayyani et al. JNCI-Journal of the National Cancer Institute
- The tyrosine kinase inhibitor dasatinib dysregulates bone remodeling through inhibition of osteoclasts in vivo
- (2010) Kate Vandyke et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Denosumab: Second Chapter in Controlling Bone Metastases or a New Book?
- (2010) Monica N. Fornier JOURNAL OF CLINICAL ONCOLOGY
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines
- (2008) Tanja D. de Gruijl et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance
- (2008) M. B. Meads et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now